![Stephen Fawell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Fawell
Directeur/Bestuurslid bij
C4 THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2026
Profiel
Stephen Fawell is an Independent Director at C4 Therapeutics, Inc. starting in 2024.
Formerly, Dr. Fawell was Executive Director-Drug Discovery at Novartis Institutes for Biomedical Research, Inc. Education includes an undergraduate degree from the University of Bradford and a doctorate from the University of Leeds.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Stephen Fawell
| Bedrijven | Functie | Begin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Bestuurslid | 29-08-2024 |
Eerdere bekende functies van Stephen Fawell
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Opleiding van Stephen Fawell
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Bradford
 University of Bradford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Kies MarketScreener 
